title: T cell CD3ζ deficiency enables multiorgan tissue inflammation.
abstract: Although a population of T cells with CD3ζ chain deficiency has been found in patients with systemic lupus erythematosus, rheumatoid arthritis, cancer, and infectious disease, the role of CD3ζ chain in the disease pathogenesis remains unknown. To understand the contribution of CD3ζ deficiency to the expression of organ injury, we have performed the following studies. We used CD3ζ-deficient mice to investigate the role of CD3ζ in the pathogenesis of organ tissue inflammation. We found that the CD3ζ(-/-) mice can spontaneously develop significant organ inflammation that can be accelerated following the administration of polyinosinic:polycytidylic acid or allogeneic cells (graft versus host). T cells from CD3ζ(-/-) mice display increased expression of the adhesion molecules CD44 and CCR2 and produce increased amounts of IFN-γ blockade, which mitigates tissue inflammation. Our results demonstrate that CD3ζ deficiency bestows T cells with the ability to infiltrate various tissues and instigate inflammation. Decreased CD3ζ expression noted in T cells from various diseases contributes independently to tissue inflammation and organ damage. Approaches to restore CD3ζ expression of the surface of T cells should be expected to mitigate tissue inflammation.
authors: Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115;
authors: Guo-Min
authors: GM
authors: Deng
authors: Jessica
authors: J
authors: Beltran
authors: Chen
authors: C
authors: Chen
authors: Cox
authors: C
authors: Terhorst
authors: George C
authors: GC
authors: Tsokos
mesh_terms: D000818:Animals; D017252:CD3 Complex / Q000235:genetics*; D005260:Female; D006086:Graft vs Host Disease / Q000235:genetics / Q000276:immunology / Q000473:pathology; D007249:Inflammation / Q000235:genetics* / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D013154:Spleen / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism*
chemical_list: D017252:CD3 Complex; C121704:CD3 antigen, zeta chain
references: J Immunol. 2005 Jun 15;174(12):7600-9
references: 15944260
references: Science. 1993 Aug 13;261(5123):918-21
references: 7688481
references: N Engl J Med. 2011 Dec 1;365(22):2110-21
references: 22129255
references: Arthritis Res. 2001;3(3):136-41
references: 11299053
references: Clin Immunol Immunopathol. 1996 Dec;81(3):293-302
references: 8938108
references: Ann Rheum Dis. 2009 Sep;68(9):1486-93
references: 18765427
references: Science. 1992 Dec 11;258(5089):1795-8
references: 1465616
references: Nature. 2005 Feb 24;433(7028):887-92
references: 15711573
references: J Immunol. 2004 Jun 15;172(12):7821-31
references: 15187166
references: J Immunol. 2007 Feb 1;178(3):1938-47
references: 17237445
references: N Engl J Med. 2006 May 4;354(18):1913-21
references: 16672702
references: J Immunol. 1997 Sep 15;159(6):2973-8
references: 9300721
references: J Clin Invest. 1997 Apr 15;99(8):1936-46
references: 9109438
references: J Exp Med. 1998 Apr 6;187(7):1093-101
references: 9529325
references: Trends Immunol. 2010 Jun;31(6):236-45
references: 20362509
references: J Immunol. 2005 Feb 1;174(3):1188-95
references: 15661872
references: Nat Immunol. 2003 Oct;4(10):957-64
references: 14502285
references: J Immunol. 2006 Nov 15;177(10):7444-50
references: 17082664
references: J Exp Med. 1996 May 1;183(5):2109-17
references: 8642321
references: Arthritis Rheum. 1999 Sep;42(9):1908-16
references: 10513807
references: Nat Med. 1995 Jun;1(6):558-63
references: 7585123
references: J Clin Invest. 1998 Apr 1;101(7):1448-57
references: 9525988
references: J Immunol. 2008 Aug 1;181(3):2211-9
references: 18641361
references: Annu Rev Immunol. 1999;17:467-522
references: 10358766
references: J Clin Invest. 1996 Sep 15;98(6):1290-7
references: 8823293